|
Sign In to gain access to subscriptions and/or personal tools.
|
Microvesicular Steatosis Induced by a Short Chain Fatty Acid: Effects on Mitochondrial Function and Correlation with Gene Expression
Robert A. Jolly
Abbott Laboratories, North Chicago, Illinois 60064, USA
Rita Ciurlionis
Abbott Laboratories, North Chicago, Illinois 60064, USA
David Morfitt
Abbott Laboratories, North Chicago, Illinois 60064, USA
Mary Helgren
Abbott Laboratories, North Chicago, Illinois 60064, USA
Reid Patterson
Abbott Laboratories, North Chicago, Illinois 60064, USA
Roger G. Ulrich
Rosetta Inpharmatics, Kirkland, Washington 98109, USA
Jeffrey F. Waring
Abbott Laboratories, North Chicago, Illinois 60064, USA, jeff.waring{at}abbott.com
Hepatotoxicity characterized by microvesicular steatosis (MVS) is characterized by an abnormal accumulation of numerous small cytoplasmic lipid droplets in hepatocytes. Fulminant or progressive cases of microvesicular steatosis may lead to liver failure and death. Experimentally, short-chain carboxylic acids are known to induce microvesicular steatosis. The identification of gene changes that correlate with MVS concomitant with biochemical and histological indices could provide a better understanding of how this toxicity occurs as well as biomarkers that could be used to avoid this toxicity in the future. Sprague—Dawley rats were dosed days with cyclopropane carboxylic acid (CPCA) a short-chain fatty acid that can induce microvesicular steatosis, and with butyrate, a short chain fatty acid that served as a negative control. CPCA initiated microvesicular steatosis while butyrate did not. In addition, CPCA inhibited beta-oxidation in a concentration-dependent manner in vitro and caused a reduction in mitochondrial respiration ex vivo; no inhibition was evident with butyrate. Microarray results showed that gene expression changes with CPCA resulted in regulation of genes involved in beta-oxidation, as well as other genes associated with mitochondrial function. Overall, these results support altered hepatic mitochondrial function as a mechanism of the toxicity induced by a short-chain fatty acid and may provide potential biomarkers for this toxicity.
Key Words: Cyclopropane carboxylic acid microvesicular steatosis mitochondrial respiration toxicogenomics microarray beta oxidation.
References
- Bulera, S.J., Eddy, S.M., Ferguson, E., Jatkoe, T.A., Reidel, J.F., Bleavins, M.R., and DeLaIglesia, F.A. (2001). RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33(5), 1239—58.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Burczynski, M.E., McMillian, M., Cirvo, J., Li, L., Parker, J.B., Dunn, R.T., Hicken, S., Farr, S., and Johnson, M.D. (2000). Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol Sci 58, 399—415.[Abstract/Free Full Text]
- Dahlquist, K.D., Salomonis, N., Vranizan, K., Lawlor, S.C., and Conklin, B.R. (2002). GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31(1), 19—20.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Doniger, S.W., Salomonis, N., Dahlquist, K.D., Vranizan, K., Lawlor, S.C., and Conklin, B.R. (2003). MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4(1), R7.
- Elliget, K.A., and Kolaja, G.J. (1983). Preparation of primary cultures of rat hepatocytes suitable for in vitro toxicity testing. J Tissue Culture Meth 8, 1—6.[Medline]
[Order article via Infotrieve]
- Hamadeh, H.K., Bushel, P.R., Jayadev, S., DiSorbo, O., Bennett, L., Li, L., Tennant, R., Stoll, R., Barrett, J.C., Paules, R.S., Blanchard, K., and Afshari, C.A. (2002). Prediction of compound signature using high density gene expression profiling. Toxicol Sci 67(2), 232—40.[Abstract/Free Full Text]
- Harries, H.M., Fletcher, S.T., Duggan, C.M., and Baker, V.A. (2001). The use of genomics technology to investigate gene expression changes in cultured human cells. Toxicol In Vitro 15, 399—405.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Holden, P.R., James, N.H., Brooks, A.N., Roberts, R.A., Kimber, I., and Pennie, W.D. (2000). Identification of a possible association between carbon tetrachloride-induced hepatotoxicity and interleukin-8 expression. J Biochem Mol Toxicol 14(5), 283—90.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jaeschke, H., Gores, G.J., Cederbaum, A.I., Hinson, J.A., Pessayre, D., and Lemasters, J.J. (2002). Mechanisms of Hepatotoxicity. Toxicol Sci 65, 166—76.[Abstract/Free Full Text]
- Kesterson, J.W., Granneman, G.R., and Machinist, J.M. (1984). The hepatotoxicity of valproic acid and its metabolites in rats. Toxicologic, biochemical and histopathologic studies. Hepatology 4(6), 1143—52.[Web of Science][Medline]
[Order article via Infotrieve]
- Lewis, J.H., Zimmerman, H.J., Garrett, C.T., and Rosenberg, E. (1982). Valproate-induced hepatic steatogenesis in rats. Hepatology 6, 870—3.
- Lim, M.L., Lum, M.G., Hansen, T.M., Roucou, X., and Nagley, P. (2002). On the release of cytochrome c from mitochondria during cell death signaling. J Biomed Sci 9(6 Pt1), 488—506.[Web of Science][Medline]
[Order article via Infotrieve]
- Losher, W., Wahnschaffe, U., Honack, D., Wittfoht, W., and Nau, H. (1992). 1992 Effects fo valproate and E-2-en-valproate on functional and morphological parameters of rat liver. Biochemical, histopathological and pharmacokinetic studies. Epilepsy Res 13, 187—98.
- Otto, D.A., Chatzidakis, C., Kaziba, E., and Cook, G.A. (1985). Reciprocal effects of 5-(tetradecyloxy)-2-furoic acid on fatty acid oxidation. Arch Biochem Biophys 242(1), 23—31.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Pessayre, D., Mansouri, A., Haouzi, D., and Fromenty, B. (1999). Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 15(6), 367—73.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Radeva-Domuschieva, D., Maglova, L.M., Balevska, P.S., Holmuhamedov, E.L., and Evtodienko, Y.V. (1986). The influence of starvation on some characteristics of the Ca2+ transport system and lipid content in rat liver mitochondria. Acta Physiol Pharmacol Bulg 12(2), 49— 54.[Medline]
[Order article via Infotrieve]
- Rehnmark, S., Giometti, C.S., Slavin, B.G., Doolittle, M.H., and Reue, K. (1998). The fatty liver dystrophy mutant mouse: microvesicular steatosis associated with altered expression levels of peroxisome proliferatorregulated proteins. J Lipid Res 39, 2209—17.[Abstract/Free Full Text]
- Reid, A.E. (2001). Nonalcoholic steatohepatitis. Gastroenterology 121, 710—23.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Reilly, T.P., Bourdi, M., Brady, J.N., Pise-Masison, C.A., Radonovich, M.F., George, J.W., and Pohl, L.R. (2001). Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem Biophys Res Comm 282, 321—8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Thomas, R.S., Rank, D.R., Penn, S.G., Zastrow, G.M., Hayes, K.R., Pande, K., Glover, E., Silander, T., Craven, M.W., Reddy, J.K., Jovanovich, S.B., and Bradfield, C.A. (2001). Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 60, 1189—94.[Abstract/Free Full Text]
- Ulrich, R.G., Bacon, J.A., Brass, E.P., Cramer, C.T., Petrella, D.K., and Sun, E.L. (2001). Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Chem Biol Interact 134(3), 251—70.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ulrich, R.G., Bacon, J.A., Cramer, C.T., Petrella, D.K., Sun, E.L., Meglasson, M.D., and Holmuhamedov, E. (1998). Disruption of mitochondrial activities in rabbit and human hepatocytes by a quinoxalinone anxiolytic and its carboxyic acid metabolite. Toxicology 131(1), 33—47.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Waring, J.F., Ciurlionis, R., Jolly, R.A., Heindel, M., and Ulrich, R.G. (2001a). Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 120, 359—68.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Waring, J.F., Gum, R., Morfitt, D., Jolly, R.A., Ciurlionis, R., Heindel, M., Gallenberg, L., Buratto, B., and Ulrich, R.G. (2002). Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. Toxicology 181—182, 537— 50.
- Waring, J.F., Jolly, R.A., Ciurlionis, R., Lum, P.Y., Praestgaard, J.T., Morfitt, D.C., Buratto, B., Roberts, C., Schadt, E., and Ulrich, R.G. (2001b). Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol 175(1), 28—42.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yang, S., Lin, H.Z., Hwang, J., Chacko, V.P., and Diehl, A.M. (2001). Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61(13), 5016—23.[Abstract/Free Full Text]
- Zimmerman, H.J. (1999). Hepatotoxicity. Lippincott, Williams & Wilkins, Philadelphia.
Toxicologic Pathology, Vol. 32, No. 2 suppl,
19-25 (2004)
DOI: 10.1080/01926230490451699

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|